Lumretuzumab

Monoclonal antibody From Wikipedia, the free encyclopedia

Lumretuzumab (INN; development code RG7116) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2][3]

TypeWhole antibody
SourceHumanized (from mouse)
TargetERBB3
Other namesRG7116
Quick facts Monoclonal antibody, Type ...
Lumretuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetERBB3
Clinical data
Other namesRG7116
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6512H10064N1736O2052S44
Molar mass146916.88 g·mol−1
Close

This drug was developed by Genentech/Roche.

References

Related Articles

Wikiwand AI